Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,936 | -17,882 | -9,487 | -6,293 | -4,655 |
| Depreciation Amortization | 615 | 1,417 | 711 | 945 | 397 |
| Other Working Capital | 1,699 | 192 | 867 | -4,177 | -5,652 |
| Other Operating Activity | 830 | -240 | -390 | 2,717 | 935 |
| Operating Cash Flow | $-5,792 | $-16,513 | $-8,299 | $-6,808 | $-8,975 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -1,716 | -1,153 | 0 | 0 |
| Investing Cash Flow | $N/A | $-1,716 | $-1,153 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,848 | 2,703 | 12 | 21,003 | 17,270 |
| Financing Cash Flow | $3,848 | $2,703 | $12 | $21,003 | $17,270 |
| Exchange Rate Effect | -10 | 852 | 407 | -131 | -540 |
| Beginning Cash Position | 4,841 | 20,014 | 20,097 | 6,548 | 6,411 |
| End Cash Position | 2,888 | 5,340 | 11,065 | 20,613 | 14,166 |
| Net Cash Flow | $-1,954 | $-14,674 | $-9,032 | $14,065 | $7,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,792 | -16,513 | -8,299 | -6,808 | -8,975 |
| Free Cash Flow | -5,792 | -16,513 | -8,299 | -6,808 | -8,975 |